Prothrombin Complex Concentrate Market Size, Share, Trends, Growth Outlook

Prothrombin Complex Concentrate Market is estimated to increase at a growth rate of 10.1% CAGR over the forecast period from 2024 to 2030.

The global Prothrombin Complex Concentrate Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (3-factor PCC, 4-factor PCC), By Application (Acquired Coagulation Factor Deficiency, Congenital Coagulation Factor Deficiency, Others), By End-user (Hospital & Ambulatory Surgical Centers, Specialty Clinics, Others).

An introduction to Prothrombin Complex Concentrate Market in 2024

Managing bleeding disorders and coagulopathy, the Prothrombin Complex Concentrate Market offers plasma-derived or recombinant concentrates containing clotting factors II, VII, IX, and X for the treatment of hemophilia, vitamin K deficiency, and acquired coagulopathies. Prothrombin complex concentrates (PCCs) are used to rapidly reverse anticoagulant effects, control bleeding, and manage perioperative coagulopathy in patients with clotting factor deficiencies or bleeding complications. This market encompasses PCC products, hemostatic agents, and coagulation factor concentrates supplied by pharmaceutical companies, blood banks, and specialty pharmacies. The growth of this market is driven by factors such as the increasing prevalence of hemostatic disorders, the rising demand for blood clotting factors, and advancements in PCC formulations and delivery systems improving treatment efficacy and safety profiles.

Prothrombin Complex Concentrate market Trend: Increasing Use in Reversal of Oral Anticoagulants

A significant trend in the Prothrombin Complex Concentrate market is the growing use of these concentrates for the reversal of oral anticoagulants such as direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs). With the rising prevalence of atrial fibrillation, venous thromboembolism, and other thrombotic disorders, the use of oral anticoagulants has increased. Prothrombin complex concentrates offer a rapid and effective reversal of anticoagulation in emergency situations, surgeries, or bleeding events, driving their adoption and demand in clinical practice.

Prothrombin Complex Concentrate market Driver: Need for Rapid Reversal of Coagulopathy in Bleeding Patients

A key driver in the Prothrombin Complex Concentrate market is the critical need for rapid reversal of coagulopathy in bleeding patients, particularly those undergoing urgent surgeries, experiencing traumatic injuries, or presenting with major bleeding events. Prothrombin complex concentrates contain factors II, VII, IX, and X, along with proteins C and S, facilitating the rapid restoration of hemostasis by replenishing deficient clotting factors and promoting thrombin generation. The ability of prothrombin complex concentrates to quickly correct coagulopathy and control bleeding improves patient outcomes and reduces the risk of morbidity and mortality, driving their essential role in managing bleeding disorders and critical care scenarios.

Prothrombin Complex Concentrate market Opportunity: Expansion into New Indications and Patient Populations

An enticing opportunity in the Prothrombin Complex Concentrate market lies in the expansion into new indications and patient populations beyond the current standard of care. While prothrombin complex concentrates are primarily used for the reversal of vitamin K antagonist-induced anticoagulation and the management of bleeding disorders, there is potential for exploring their efficacy in other clinical settings, such as perioperative management, liver disease-associated coagulopathy, and off-label indications. By conducting clinical trials and obtaining regulatory approvals for expanded indications, manufacturers can capitalize on the growing demand for prothrombin complex concentrates and address unmet medical needs in diverse patient populations, thus unlocking new market opportunities and revenue streams in the prothrombin complex concentrate market.

Prothrombin Complex Concentrate Market Market Segmentation

By Product
3-factor PCC
4-factor PCC
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
Others
By End-User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Prothrombin Complex Concentrate Market Companies

Abeona Therapeutics Inc
Biotest AG
CSL
Grifols, S.A.
Insud Pharma
Kedrion
Octapharma AG
Sanquin
Taibang Biological Group Co. Ltd
Takeda Pharmaceutical Company Ltd

Reasons to Buy the Prothrombin Complex Concentrate Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Prothrombin Complex Concentrate Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Prothrombin Complex Concentrate Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Prothrombin Complex Concentrate Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Prothrombin Complex Concentrate Market Size Outlook, $ Million, 2021 to 2030
3.2 Prothrombin Complex Concentrate Market Outlook by Type, $ Million, 2021 to 2030
3.3 Prothrombin Complex Concentrate Market Outlook by Product, $ Million, 2021 to 2030
3.4 Prothrombin Complex Concentrate Market Outlook by Application, $ Million, 2021 to 2030
3.5 Prothrombin Complex Concentrate Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Prothrombin Complex Concentrate Industry
4.2 Key Market Trends in Prothrombin Complex Concentrate Industry
4.3 Potential Opportunities in Prothrombin Complex Concentrate Industry
4.4 Key Challenges in Prothrombin Complex Concentrate Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Prothrombin Complex Concentrate Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Prothrombin Complex Concentrate Market Outlook by Segments
7.1 Prothrombin Complex Concentrate Market Outlook by Segments, $ Million, 2021- 2030
By Product
3-factor PCC
4-factor PCC
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
Others
By End-User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others

8 North America Prothrombin Complex Concentrate Market Analysis and Outlook To 2030
8.1 Introduction to North America Prothrombin Complex Concentrate Markets in 2024
8.2 North America Prothrombin Complex Concentrate Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Prothrombin Complex Concentrate Market size Outlook by Segments, 2021-2030
By Product
3-factor PCC
4-factor PCC
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
Others
By End-User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others

9 Europe Prothrombin Complex Concentrate Market Analysis and Outlook To 2030
9.1 Introduction to Europe Prothrombin Complex Concentrate Markets in 2024
9.2 Europe Prothrombin Complex Concentrate Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Prothrombin Complex Concentrate Market Size Outlook by Segments, 2021-2030
By Product
3-factor PCC
4-factor PCC
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
Others
By End-User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others

10 Asia Pacific Prothrombin Complex Concentrate Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Prothrombin Complex Concentrate Markets in 2024
10.2 Asia Pacific Prothrombin Complex Concentrate Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Prothrombin Complex Concentrate Market size Outlook by Segments, 2021-2030
By Product
3-factor PCC
4-factor PCC
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
Others
By End-User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others

11 South America Prothrombin Complex Concentrate Market Analysis and Outlook To 2030
11.1 Introduction to South America Prothrombin Complex Concentrate Markets in 2024
11.2 South America Prothrombin Complex Concentrate Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Prothrombin Complex Concentrate Market size Outlook by Segments, 2021-2030
By Product
3-factor PCC
4-factor PCC
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
Others
By End-User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others

12 Middle East and Africa Prothrombin Complex Concentrate Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Prothrombin Complex Concentrate Markets in 2024
12.2 Middle East and Africa Prothrombin Complex Concentrate Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Prothrombin Complex Concentrate Market size Outlook by Segments, 2021-2030
By Product
3-factor PCC
4-factor PCC
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
Others
By End-User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abeona Therapeutics Inc
Biotest AG
CSL
Grifols, S.A.
Insud Pharma
Kedrion
Octapharma AG
Sanquin
Taibang Biological Group Co. Ltd
Takeda Pharmaceutical Company Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
3-factor PCC
4-factor PCC
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
Others
By End-User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others